Ceramide-Infused Skin Barrier Cuts Stoma-Related Costs

Share this content:
Ceramide-Infused Skin Barrier Cuts Stoma-Related Costs
Ceramide-Infused Skin Barrier Cuts Stoma-Related Costs

FRIDAY, Jan. 12, 2018 (HealthDay News) -- Use of a ceramide-infused ostomy skin barrier is associated with reduced stoma-related cost of care, according to a study published in the January/February issue of the Journal of Wound, Ostomy and Continence Nursing.

Janice C. Colwell, R.N., from the University of Chicago Medicine, and colleagues conducted a multicentered international trial involving 153 adults from 25 sites in the United States, Canada, and Europe. Ostomy-related costs were examined and the incidence of peristomal skin complications (PSCs) was compared for ceramide-infused ostomy skin barriers and control skin barriers.

The researchers found that over a 12-week period there was a significant reduction in stoma-related cost of care with use of the ceramide-infused barrier, resulting in a 14 percent relative decrease in cost (reduction of $36.46). The adjusted average costs were $223.73 and $260.19 in the treatment and control groups, respectively (P = 0.017). The overall incidence of PSC was 47.7 percent; 40.5 and 55.4 percent for the control and treatment groups, respectively (P = 0.069; 95 percent confidence interval of the difference, −1.2 to 30.4). In the ceramide-infused skin barrier group, significantly more participants were very satisfied with barrier performance, prevention of leakage, and prevention of itching. Both groups had general postoperative improvement in health-related quality of life.

"The use of a ceramide-infused barrier significantly decreased cost and increased satisfaction with patient-reported outcomes," the authors write.

Several authors disclosed financial ties to medical product companies, including Hollister Incorporated, which funded the study.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use

Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use

UROPP reduces opioids prescribed after gynecologic, abdominal surgery without negative effects

Lower RN Staffing Linked to Increased In-Hospital Mortality

Lower RN Staffing Linked to Increased In-Hospital Mortality

Higher levels of admissions per registered nurse also tied to increased in-hospital mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »